Cited 2 times in
A pilot study on intermittent every other days of 5-dose Filgrastim compared with single Pegfilgrastim in breast Cancer patients receiving adjuvant Docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.